Dr. Michael J Greenberg's lab focuses on understanding the genetic causes of heart diseases, specifically cardiomyopathies, which can lead to heart failure. The team aims to develop new, more effective treatments by using a precision medicine approach that considers the unique genetic makeup of individual patients. They integrate various advanced techniques to model mutations and test how these influence heart cell and tissue function, paving the way for tailored therapies for patients with specific genetic mutations.

Dr. Iswar K. Hariharan's lab at UC Berkeley focuses on understanding how growth is regulated in living organisms, particularly through studying the development and regeneration of structures in fruit flies (Drosophila). By examining the genetic mechanisms involved during both normal growth processes and regenerative growth after injury, the lab seeks to uncover the critical interactions between different cell types. This research is vital for gaining insights into various medical conditions, including cancer and birth defects, which are influenced by growth abnormalities.

Dr. Karen Guillemin's lab at the University of Oregon studies how our gut microbiomes influence our metabolic and immune health, particularly through interactions with exercise and social behavior. The lab focuses on engineered probiotics that can mimic the health benefits of exercise, as well as understanding the role of specific bacterial proteins in promoting insulin-producing pancreatic cells. By using models like zebrafish and examining how social interactions shape microbiomes, they aim to uncover new treatments for diabetes and other health issues.

Dr. Robert Andrew Quinn's lab at Michigan State University studies how the gut microbiome interacts with bile acids, which are crucial for digestion and gut health. They focus on a group of bile acids modified by gut bacteria, called microbially conjugated bile acids (MCBAs), and investigate how these compounds can influence inflammation and health outcomes in diseases like inflammatory bowel disease. Through their research, they aim to understand the potential of MCBAs as new therapeutic agents for gut-related conditions.

Dr. Peter Turnbaugh's lab focuses on understanding how the gut microbiome influences the metabolism of cancer drugs, particularly fluoropyrimidines used in colorectal cancer treatment. By examining the interactions between gut bacteria and these drugs, the research aims to reveal why there are differences in drug effectiveness and side effects among patients. This work could lead to better treatment strategies that take into account individual differences in gut microbiota.

Dr. Harris H. Wang's lab focuses on understanding the complex ecosystems of microorganisms in the gastrointestinal tract, emphasizing how their spatial distribution impacts health and disease. By using advanced techniques like spatial metagenomics and single-cell genomics, the lab investigates how the gut microbiome contributes to digestion, immune responses, and recovery from infections, such as Clostridioides difficile. Their innovative approaches aim to enhance our understanding of microbial roles and pave the way for better microbiome-based therapies.

Dr. Stavroula Hatzios's lab at Yale University conducts research on how microbial infections contribute to cancer development. By focusing on oxidative stress, which is often caused by infections, they study how specific sites on proteins are modified and impact cellular functions. The lab utilizes innovative techniques to uncover these modifications, aiming to establish new therapeutic strategies to combat cancer linked to infections.

Dr. Nissim Hay's lab at the University of Illinois at Chicago focuses on understanding the role of Hexokinase 2 (HK2) in liver fibrosis and liver cancer. The lab investigates how HK2 contributes to the metabolic changes in liver cells during disease and looks for ways to leverage this knowledge for new treatments. Additionally, they explore HK2's role in cancer cell metabolism and its potential as a therapeutic target in various cancers.

Dr. Chuan He's research lab at the University of Chicago focuses on understanding DNA modifications, particularly epigenetic changes that affect gene expression. They are developing new methods to label and sequence specific chemical changes in DNA, particularly 5-hydroxymethylcytosine and 5-methylcytosine, which may have significant implications for diagnosing and treating diseases. This research is crucial for both basic science and clinical applications, promising advancements in how we study and understand genetics and health.

Dr. Ekaterina Heldwein's lab at Tufts University studies how herpesviruses exit the nucleus of infected cells to spread and cause disease. The team focuses on understanding the molecular mechanisms of virus membrane budding and fusion, particularly looking at proteins involved in these processes. Their research has implications for developing better vaccines and treatments for viral infections, especially in vulnerable populations.

Dr. Song Tan's lab at Penn State is focused on understanding how proteins that modify histones—the proteins that package DNA—regulate gene expression in cells. By studying the structures of these proteins and their interactions with nucleosomes, the lab aims to reveal mechanisms behind gene regulation, particularly in the context of diseases like cancer. This research not only deepens our understanding of fundamental biological processes but also holds potential for developing new therapies targeting gene regulation.

Dr. Michal Toborek's lab at the University of Miami School of Medicine studies how HIV infection and substance use, particularly methamphetamine, affect brain health and contribute to disorders such as depression. They focus on understanding the interactions between HIV and brain cells, especially in how these conditions interfere with the blood-brain barrier and influence the gut-brain connection. Through their research, they aim to uncover mechanisms that could lead to new treatments for individuals affected by HIV, especially as they age.

The Xiong laboratory at Yale University focuses on understanding the life cycle of HIV-1, particularly how the virus matures and enters the nucleus of host cells. By using advanced imaging techniques like cryo-electron microscopy, the lab investigates the structural changes that occur during the maturation of the HIV-1 capsid and how this process can be inhibited by certain drugs. Their research aims to advance our understanding of HIV-1 biology and contribute to the development of new anti-HIV therapies.

Dr. Jonathan Karn's lab at Case Western Reserve University focuses on understanding how HIV persists in the body, particularly in the brain, and how different factors, such as RNA modifications and substance use, influence this process. The lab works to develop new methods for studying HIV latency and reactivation using advanced techniques such as next-generation sequencing and induced pluripotent stem cells. By deciphering the complex interactions between HIV and the brain, the lab aims to contribute to better treatments for HIV-associated neurocognitive disorders.

Dr. Hashim Al-Hashimi's lab at Columbia University focuses on understanding how HIV-1, the virus that causes AIDS, regulates its own replication through RNA structures. By studying the dynamics of RNA and its interactions with proteins, the lab aims to create models that predict how these processes work at a molecular level. This research could lead to new strategies for developing targeted therapies that impede the virus's ability to replicate.

Dr. Sara Sawyer's lab focuses on combating HIV/AIDS through innovative research that seeks to develop a new animal model for studying the virus. This model aims to provide critical insights into virus behavior and how it spreads, which will help in the search for effective vaccines and cures. The lab's work is intended to address the limitations present in current research methods, ultimately aiming to save lives affected by this global health crisis.

Michael Cianfrocco's lab at the University of Michigan focuses on understanding how the HIV-1 virus navigates within host cells. Their research aims to uncover the molecular mechanisms that allow HIV-1 to exploit cellular transport systems, particularly the dynein motor proteins, to reach the nucleus of the infected cell. By investigating these interactions, the lab hopes to identify new therapeutic targets to prevent HIV-1 infection and improve treatment options.

Scott Holley's lab at Yale University studies how the body of zebrafish develops, focusing on understanding the early stages of spinal column formation. Using zebrafish as a model organism, the research explores the mechanisms behind human developmental issues, such as scoliosis and spina bifida. The lab combines various techniques like genetics and live imaging to uncover how cells interact and organize during development, contributing to a more profound understanding of biological order and developmental stability.

James Holton's lab focuses on structural biology, particularly understanding how the structures of macromolecules relate to their functions. They develop new methods and tools for accurate molecular modeling and data collection to bridge the gap between predicted and real structures of biological molecules. By improving the resolution and accuracy of imaging techniques, the lab aims to unlock deeper insights into essential biological processes and drug design.

Dr. Graeme W. Davis's lab at UCSF studies homeostatic plasticity, which helps neurons stabilize their function in response to changes. Their research focuses on the mechanisms linking this plasticity to neurodevelopmental disorders, mental health, and age-related declines in neuromuscular function. By investigating these connections, the lab aims to explore new therapeutic strategies for conditions like Jordan's Syndrome and other neurodegenerative diseases.